Public Company News
Qudian Inc. Reports Second Quarter 2022 Unaudited Financial Results
XIAMEN, China, Sept. 6, 2022 /PRNewswire/ -- Qudian Inc. ("Qudian" or "the Company" or "We") (NYSE: QD), a consumer-oriented technology company inChina, today announced its unaudited financial results for the quarter endedJune 30, 2022. Second Quarter 2022 Operational Highlights: * Number of...
2022-09-06 18:00
4180
Trip.com Group Limited to Report Second Quarter and First Half of 2022 Financial Results on September 21, 2022 U.S. Time
SHANGHAI, Sept. 6, 2022 /PRNewswire/ -- Trip.com Group Limited (Nasdaq: TCOM; HKEX: 9961), a leading one-stop travel service provider of accommodation reservation, transportation ticketing, packaged tours and corporate travel management, will announce its financial results for the three months an...
2022-09-06 18:00
3329
TAL Education Group to Hold Annual General Meeting on September 16, 2022
BEIJING, Sept. 6, 2022 /PRNewswire/ -- TAL Education Group (NYSE: TAL) ("TAL" or the "Company"), a smart learning solutions provider inChina, today announced that it will hold its annual general meeting of shareholders at 4/F Heying Center,Xiaoying West Street, Haidian District, Beijing, China, o...
2022-09-06 17:30
3667
Amcor reveals Lift-Off seed capital winners with investments that seek to "drive the revolution in packaging"
Global packaging leader to provide US $250,000 to two start-ups with cutting edge innovations for a more sustainable future for packaging ZURICH, Sept. 6, 2022 /PRNewswire/ -- Amcor (NYSE: AMCR, ASX: AMC), a global leader in developing and producing responsible packaging solutions, has announced...
2022-09-06 16:10
3948
Jacobio Receives CDE Approval for KRAS G12C Inhibitor JAB-218822's Phase II Pivotal Study in China
BEIJING, SHANGHAI and BOSTON, Sept. 6, 2022 /PRNewswire/ -- Jacobio Pharma (1167.HK) has received Phase II pivotal study approval of KRAS G12C inhibitor JAB-21822 from the Center for Drug Evaluation (CDE) ofChina in September 5, 2022 . This study aims to treat advanced or metastatic non-small cell...
2022-09-06 15:20
2500
SK hynix to Build M15X Fab in Cheongju
* Company to break ground in October, complete construction in early 2025 with plan to invest15 trillion won over 5 years * M15X to be first new fab since company commemorated 10th anniversary this year * Investment during economic downturn to lay foundation for future growth SEOUL, South K...
2022-09-06 14:15
2775
MingZhu Logistics Updates Instructions to Participate in 2022 Annual Meeting via Video Conferencing
SHENZHEN, China, Sept. 5, 2022 /PRNewswire/ -- MingZhu Logistics Holdings Ltd. (NASDAQ: YGMZ) (the "MingZhu" or "Company"), a trucking service provider, today announced updated instructions to participate in the Company's 2022 Annual Meeting via video conferencing to accommodate ongoing COVID con...
2022-09-06 07:45
2456
Dizal Announces Sunvozertinib Meets Primary Endpoint in its First Pivotal Study in Platinum-Pretreated NSCLC Patients with EGFR Exon20ins Mutations at 2022 ESMO
* The confirmed objective response (cORR), as assessed by blinded independent central review (BICR), was 59.8% in advanced NSCLC with EGFR exon20ins mutations after at least one line of platinum-based chemotherapies * The response rate for patients with baseline brain metastasis was 48.4% * ...
2022-09-05 22:49
3500
Dizal Announces Positive Phase I Clinical Trial Results for DZD1516 in Treating HER2 Breast Cancer at 2022 ESMO
PARIS, Sept. 5, 2022 /PRNewswire/ -- Dizal reported the promising safety and pharmacokinetic data from the global Phase I study ofDZD1516 in patients with HER2 positive metastatic breast cancer (HER2+ MBC) who relapsed from multiple prior treatments at the 2022 European Society for Medical Oncolo...
2022-09-05 22:39
3274
GONEO launches the new silent series portable power stations
The series provides users with a comfortable noise-free experience when using
electricity outdoors
NINGBO, China, Sept. 5, 2022 /PRNewswire/ -- GONEO
2022-09-05 21:15
5686
Recruitment opens for Phase II trial in prostate cancer with Cu-64 SAR-Bombesin in the US
SYDNEY, Sept. 5, 2022 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity"), a clinical stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for children and adults with cancer, is pleased to announce that the US-based diagn...
2022-09-05 21:09
3427
Lunit to Showcase 5 Abstracts at ESMO 2022
* Lunit to present five posters at ESMO 2022 featuring the company's AI-biomarker platform * Studies corroborate the capability of Lunit SCOPE suite to address an expanding set of clinical and research questions based on world-leading digital pathology AI SEOUL, South Korea, Sept. 5, 2022 /PR...
2022-09-05 21:00
3437
Boqii Announces Senior Management Change
SHANGHAI, Sept. 5, 2022 /PRNewswire/ -- Boqii Holding Limited ("Boqii" or the "Company") (NYSE: BQ), a leading pet-focused platform inChina, today announced that Mr.Kai Fang has resigned from his position as the Company's Chief Strategy Officer and all his roles as a director or an officer of the...
2022-09-05 20:00
3629
JDDJ at CIFTIS: On-demand retail in action to assist real economy and boost consumption
BEIJING, Sept. 5, 2022 /PRNewswire/ -- As the only on-demand retail industry representative at the New Digital Consumption Forum of the China International Fair for Trade in Services (CIFTIS) inBeijing this year, General Manager of JDDJ Mr.Changming Li gave a speech to discuss how JDDJ supports r...
2022-09-05 19:50
3855
Vernalis Research, a fully owned subsidiary of HitGen Inc., and Unison Medicines Inc. announce a research collaboration in the field of anti-infectives
CHENGDU, China, Sept. 5, 2022 /PRNewswire/ -- Vernalis Research ("Vernalis"), a fully owned subsidiary of HitGen Inc., and Unison Medicines Inc. ("Unison") are pleased to announce a research collaboration on an undisclosed bacterial target. Under the terms of the agreement, Vernalis will use it...
2022-09-05 16:00
3515
Simcere Pharmaceutical Announces Financial Results for 2022 H1: 27% Year-Over-Year Revenue Growth, with Innovative Drugs Accounting for 65.4% of Total Revenue
NANJING, China, Sept. 5, 2022 /PRNewswire/ -- Simcere Pharmaceutical Group Limited (2096.HK) announced its financial results for the first half of 2022. As ofJune 30, Simcere recorded operating revenue of RMB 2.7 billion for the first half of the year, with a year-over-year growth of 27.3%. The e...
2022-09-05 13:09
4550
Tamas Oravecz Ph.D. named SVP, CSO of the U.S. of Simcere Pharmaceutical Group
NANJING, China, Sept. 5, 2022 /PRNewswire/ -- Simcere Pharmaceutical Group announces today the appointment ofTamas Oravecz, Ph.D. as Senior Vice President, Chief Scientific Officer of the Simcere U.S. Tamas will be responsible for providing strategic leadership to our drug discovery efforts in A...
2022-09-05 13:08
3585
Dada Now on WAIC: AI brings better efficiency and customer experience for on-demand delivery
SHANGHAI, Sept. 5, 2022 /PRNewswire/ -- Dada Group (NASDAQ: DADA)'s Dada Now is a leading local on-demand delivery platform inChina, providing indispensable delivery infrastructure to local retail in the new era. Bing FU, General Manager of Dada Now, gave a speech on the topic "AI empowers on-dem...
2022-09-05 12:06
3375
Addentax Group Corp. Announces Uplisting to Nasdaq Capital Market and Closing of $25 Million Public Offering of Common Stock
SHENZHEN, China, Sept. 2, 2022 /PRNewswire/ -- Addentax Group Corp. ("Addentax" or the "Company") (NasdaqCM: ATXG), an integrated service provider focusing on garment manufacturing, logistics service, property management and subleasing, and epidemic prevention supplies, today announced the closin...
2022-09-02 22:51
10263
ReneSola Announces a Repurchase Transaction with ReneSola Singapore and Enters into a New Investor Rights Agreement with Shah Capital
--Share Repurchase from ReneSola Singapore
--New Investor Rights Agreement with Shah Capital
--Departure of Two Board Members
STAMFORD, Conn., Sept. 2, 2022 /PRNewswire/ -- ReneSola Ltd ("ReneSola" or
the "Company") (www.renesolapower.com
2022-09-02 21:00
6470
Week's Top Stories
Most Reposted
HLB's Flagship CIO Fund Launched with Strategic Alliance with Lombard Odier
[Picked up by 281 media titles]
2026-09-28 23:04
Responsible Fintech Institute Appoints Four Executive Fellows and Elevates Distinguished Professor Patrick H. M. Loh to Co-Founder
[Picked up by 279 media titles]
2026-09-29 09:00
ViewSonic Launches VG1457 Dual-Screen Portable Monitor for Productivity Anywhere
[Picked up by 269 media titles]
2026-09-30 10:50
Allianz Partners unveils next-generation travel insurance platform to help partners navigate changing landscape
[Picked up by 269 media titles]
2026-09-28 07:30
Zenika CTO Adrien Nortain Moves Base to Singapore to Strengthen Technical Leadership in Asia
[Picked up by 267 media titles]
2026-10-01 10:00
Most Read
MixVio AI Launches Unified Creative Workspace Across 26 AI Generation Routes
2026-10-02 00:30
23247
